Morilla R - Search Results

1

Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial.

Blakemore SJ, Clifford R, Parker H, Antoniou P, Stec-Dziedzic E, Larrayoz M, Davis Z, Kadalyayil L, Colins A, Robbe P, Vavoulis D, Forster J, Carr L, Morilla R, Else M, Bryant D, McCarthy H, Walewska RJ, Steele AJ, Chan J, Speight G, Stankovic T, Cragg MS, Catovsky D, Oscier DG, Rose-Zerilli MJJ, Schuh A, Strefford JC. Blakemore SJ, et al. Among authors: morilla r. Leukemia. 2020 Jul;34(7):1760-1774. doi: 10.1038/s41375-020-0723-2. Epub 2020 Feb 3. Leukemia. 2020. PMID: 32015491 Free PMC article. Clinical Trial.

2

The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial.

Oscier D, Else M, Matutes E, Morilla R, Strefford JC, Catovsky D. Oscier D, et al. Among authors: morilla r. Br J Haematol. 2016 Sep;174(5):767-75. doi: 10.1111/bjh.14132. Epub 2016 May 6. Br J Haematol. 2016. PMID: 27151266 Free PMC article. Clinical Trial.

3

Analysis of residual disease in chronic lymphocytic leukemia by flow cytometry.

Cabezudo E, Matutes E, Ramrattan M, Morilla R, Catovsky D. Cabezudo E, et al. Among authors: morilla r. Leukemia. 1997 Nov;11(11):1909-14. doi: 10.1038/sj.leu.2400835. Leukemia. 1997. PMID: 9369425

4

Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia.

Thornton PD, Gruszka-Westwood AM, Hamoudi RA, Atkinson S, Kaczmarek P, Morilla RM, Hilditch BL, A'Hern R, Matutes E, Catovsky D. Thornton PD, et al. Among authors: morilla rm. Hematol J. 2004;5(1):47-54. doi: 10.1038/sj.thj.6200325. Hematol J. 2004. PMID: 14745430

5

Combinations of ZAP-70, CD38 and IGHV mutational status as predictors of time to first treatment in CLL.

Morilla A, Gonzalez de Castro D, Del Giudice I, Osuji N, Else M, Morilla R, Brito Babapulle V, Rudenko H, Matutes E, Dearden C, Catovsky D, Morgan GJ. Morilla A, et al. Among authors: morilla r. Leuk Lymphoma. 2008 Nov;49(11):2108-15. doi: 10.1080/10428190802360810. Leuk Lymphoma. 2008. PMID: 19021053

6

Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia.

Rossi E, Matutes E, Morilla R, Owusu-Ankomah K, Heffernan AM, Catovsky D. Rossi E, et al. Among authors: morilla r. Leukemia. 1996 Mar;10(3):494-7. Leukemia. 1996. PMID: 8642868

7

Adhesion receptors on peripheral blood leukemic B cells. A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias.

Csanaky G, Matutes E, Vass JA, Morilla R, Catovsky D. Csanaky G, et al. Among authors: morilla r. Leukemia. 1997 Mar;11(3):408-15. doi: 10.1038/sj.leu.2400582. Leukemia. 1997. PMID: 9067581

8

CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia.

Thornton PD, Fernandez C, Giustolisi GM, Morilla R, Atkinson S, A'Hern RP, Matutes E, Catovsky D. Thornton PD, et al. Among authors: morilla r. Hematol J. 2004;5(2):145-51. doi: 10.1038/sj.thj.6200360. Hematol J. 2004. PMID: 15048065 Clinical Trial.

9

CD34 and CD117 are overexpressed in AML and may be valuable to detect minimal residual disease.

Scolnik MP, Morilla R, de Bracco MM, Catovsky D, Matutes E. Scolnik MP, et al. Among authors: morilla r. Leuk Res. 2002 Jul;26(7):615-9. doi: 10.1016/s0145-2126(01)00182-5. Leuk Res. 2002. PMID: 12008077

10

Oestrogen receptor (ER) analysis in B-cell chronic lymphocytic leukemia: correlation of biochemical and immunocytochemical methods.

Melo N, Hobday C, Dowsett M, Catovsky D, Matutes E, Morilla R, Polliack A. Melo N, et al. Among authors: morilla r. Leuk Res. 1990;14(11-12):949-52. doi: 10.1016/0145-2126(90)90106-j. Leuk Res. 1990. PMID: 2280609

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

117 results

Search Page